X-71372432-CAAAAAAAAAAAAAA-CAAAAAAAAAAAAA

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_004606.5(TAF1):​c.353-2709delA variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 995 hom., 57 hem., cov: 0)
Failed GnomAD Quality Control

Consequence

TAF1
NM_004606.5 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00

Publications

0 publications found
Variant links:
Genes affected
TAF1 (HGNC:11535): (TATA-box binding protein associated factor 1) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]
TAF1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked, syndromic 33
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • X-linked dystonia-parkinsonism
    Inheritance: XL, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF1NM_004606.5 linkc.353-2709delA intron_variant Intron 3 of 37 ENST00000423759.6 NP_004597.3 P21675

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF1ENST00000423759.6 linkc.353-2734delA intron_variant Intron 3 of 37 5 NM_004606.5 ENSP00000406549.2 P21675

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
13715
AN:
27816
Hom.:
998
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.453
Gnomad AMI
AF:
0.529
Gnomad AMR
AF:
0.576
Gnomad ASJ
AF:
0.486
Gnomad EAS
AF:
0.565
Gnomad SAS
AF:
0.603
Gnomad FIN
AF:
0.649
Gnomad MID
AF:
0.684
Gnomad NFE
AF:
0.494
Gnomad OTH
AF:
0.529
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.493
AC:
13709
AN:
27826
Hom.:
995
Cov.:
0
AF XY:
0.167
AC XY:
57
AN XY:
342
show subpopulations
African (AFR)
AF:
0.453
AC:
2902
AN:
6413
American (AMR)
AF:
0.575
AC:
901
AN:
1566
Ashkenazi Jewish (ASJ)
AF:
0.486
AC:
428
AN:
880
East Asian (EAS)
AF:
0.566
AC:
373
AN:
659
South Asian (SAS)
AF:
0.589
AC:
116
AN:
197
European-Finnish (FIN)
AF:
0.649
AC:
96
AN:
148
Middle Eastern (MID)
AF:
0.676
AC:
23
AN:
34
European-Non Finnish (NFE)
AF:
0.494
AC:
8592
AN:
17403
Other (OTH)
AF:
0.528
AC:
161
AN:
305
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
369
738
1106
1475
1844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
186

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41384445; hg19: chrX-70592282; API